RHYTHM PHARMACEUTICALS, INC. (RYTM) — Operating Income

Annual figures by fiscal year, from SEC filings.

2015: -$10.57M2016: -$25.91M2017: -$32.41M2018: -$78.42M2019: -$146.00M2020: -$136.57M2021: -$170.06M2022: -$179.16M2023: -$184.36M2024: -$265.50M2025: -$192.02M-$192.02M
2015Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$192.02M+27.7%
2024-$265.50M-44.0%
2023-$184.36M-2.9%
2022-$179.16M-5.3%
2021-$170.06M-24.5%
2020-$136.57M+6.5%
2019-$146.00M-86.2%
2018-$78.42M-141.9%
2017-$32.41M-25.1%
2016-$25.91M-145.0%
2015-$10.57M